EUVIMEDEUVIMED entdecken
Kohortenstudie

Incidence of metabolic dysfunction‐associated steatotic liver disease and advanced fibrosis and impact of overweight/obesity in elderly population: a nationwide cohort study

Kunhee Kim iD, Yaeji Lee, Jae Seung Lee iD, Mi Na Kim, Beom Kyung Kim iD, Seung Up Kim iD, Jun Yong Park, Do Young Kim iD, Sang Hoon Ahn iD, Inkyung Jung, Hye Won Lee iD

Journal of Gastroenterology and Hepatology · 2024-12 · 39 (12) · 2845-2852

DOI: 10.1111/jgh.16755 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 29.09.2024. Verfasst von Kunhee Kim und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Obesity, Liver Cirrhosis, Overweight. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Korean Association for the Study of the Liver, Korean Liver Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim The prevalence of metabolic dysfunction‐associated steatotic liver disease (MASLD) is increasing worldwide, coinciding with aging population. However, limited studies have evaluated its incidence and progression to advanced fibrosis in the elderly population. Therefore, our study aimed to investigate the incidence of MASLD and advanced fibrosis in this age group.

Methods

We included 878 686 individuals aged ≥60 years from the Korea National Health Insurance Service‐Senior cohort. After excluding participants with preexisting MASLD, 329 388 individuals were finally analyzed. Participants were categorized into four groups based on the presence of overweight/obesity and additional risk factors (aRF) included in the cardiometabolic diagnostic criteria of MASLD.

Results

The overall incidence of MASLD was 1.94 per 100 person‐years, and the incidence of advanced fibrosis in MASLD patients was 1.78 per 100 person‐years. MASLD development was significantly higher in overweight/obese patients (2.65 per 100 person‐years) compared to lean patients (1.09 per 100 person‐years), and this trend persisted after stratification by the presence of aRF. Similarly, the incidence of advanced fibrosis among MASLD patients was higher in overweight/obese individuals (2.06 per 100 person‐years) compared to lean counterparts (0.87 per 100 person‐years), irrespective of aRF.

Conclusions

The lower incidence of MASLD in the elderly population compared to the general population underscores the importance of identifying age‐specific risk factors. Overweight/obesity emerged as a robust predictor of MASLD development and advanced fibrosis. Additionally, the presence of additional cardiometabolic risk factors further increased the risk of incident MASLD and advanced fibrosis among the elderly.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityLiver CirrhosisOverweightHumansIncidenceAgedMaleFemaleMiddle AgedRepublic of KoreaCohort StudiesRisk FactorsDisease ProgressionFatty LiverAged, 80 and overAge FactorsMetabolic Diseases

Stichwörter der Autor:innen

advanced fibrosiselderlyincidencemetabolic dysfunction‐associated steatotic liver disease

Autor:innen und Institutionen

  • Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
  • Division of Biostatistics, Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, South Korea.
  • Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, South Korea.
  • Yonsei Liver Center, Severance Hospital, Seoul, South Korea.

ORCID-Profile: Kunhee Kim, Jae Seung Lee, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Hye Won Lee

Förderung

  • Korean Association for the Study of the Liver
  • Korean Liver Foundation

Zitieren

APA

Kim, K., Lee, Y., Lee, J. S., Kim, M. N., Kim, B. K., Kim, S. U., Park, J. Y., Kim, D. Y., Ahn, S. H., Jung, I., & Lee, H. W. (2024). Incidence of metabolic dysfunction‐associated steatotic liver disease and advanced fibrosis and impact of overweight/obesity in elderly population: a nationwide cohort study. Journal of Gastroenterology and Hepatology, 39(12), 2845-2852. https://doi.org/10.1111/jgh.16755

Vancouver

Kim K, Lee Y, Lee JS, Kim MN, Kim BK, Kim SU, et al. Incidence of metabolic dysfunction‐associated steatotic liver disease and advanced fibrosis and impact of overweight/obesity in elderly population: a nationwide cohort study. Journal of Gastroenterology and Hepatology. 2024;39(12):2845-2852. doi:10.1111/jgh.16755

BibTeX
@article{Kim2024,
  author = {Kim, Kunhee and Lee, Yaeji and Lee, Jae Seung and Kim, Mi Na and Kim, Beom Kyung and Kim, Seung Up and Park, Jun Yong and Kim, Do Young and Ahn, Sang Hoon and Jung, Inkyung and Lee, Hye Won},
  title = {Incidence of metabolic dysfunction‐associated steatotic liver disease and advanced fibrosis and impact of overweight/obesity in elderly population: a nationwide cohort study},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2024},
  volume = {39},
  number = {12},
  pages = {2845--2852},
  doi = {10.1111/jgh.16755}
}
Kostenlos starten →